Maladie de Fabry en cardiologie revue de la littérature et point de vue d'experts [Fabry disease in cardiology practice Literature review and expert point of view]

Abstract : Fabry disease is an X-linked progressive multisystemic genetic sphingolipidosis caused by deficient activity of lysosomal α-galactosidase A. Men aged > 30 years and women aged > 40 years most often present with unexplained left ventricular hypertrophy, usually concentric and non-obstructive, but sometimes mimicking sarcomeric hypertrophic cardiomyopathy, particularly when isolated, as in the cardiac or late-onset variant of the disease. In hypertrophic cardiomyopathy cohorts, up to 1% of patients have been diagnosed with Fabry disease. Frequent cardiac symptoms include chronotropic incompetence, severe conduction disturbances and arrhythmias, heart failure and sudden death, and cardiovascular complications are currently the leading cause of death at a mean age of 55 years in men and 66 years in women. Complementary to screening for extracardiac manifestations, the initial cardiac evaluation should include long-duration electrocardiogram recordings, echocardiography and late gadolinium and T1 mapping magnetic resonance imaging. Abnormalities of a non-hypertrophied inferolateral wall at the base of the left ventricle (thinning, decreased strain, midwall fibrosis) and low native T1 signal on magnetic resonance imaging are evocative. Aggressive cardiac management may include the control of cardiovascular risk factors, anticoagulation, permanent cardiac pacing and/or an implantable cardioverter defibrillator device, while antiarrhythmics and beta-blockers should be used with caution. Specific therapy should be initiated at the earliest stage, when the first structural or functional cardiac abnormalities are detected, and should include enzyme replacement therapy (available since 2001) or chaperone therapy (available since 2016) (the use of which is limited to patients with Fabry disease and an amenable α-galactosidase A [GLA] gene mutation). © 2019
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02088219
Contributor : Laurent Jonchère <>
Submitted on : Tuesday, April 2, 2019 - 4:31:13 PM
Last modification on : Thursday, June 13, 2019 - 1:26:20 PM

Identifiers

Citation

Albert Hagège, P. Réant, G. Habib, T. Damy, G. Barone-Rochette, et al.. Maladie de Fabry en cardiologie revue de la littérature et point de vue d'experts [Fabry disease in cardiology practice Literature review and expert point of view]. Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2019, 112 (4), pp.278-287. ⟨10.1016/j.acvd.2019.01.002⟩. ⟨hal-02088219⟩

Share

Metrics

Record views

54